Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru
Author(s) -
Carole D. Mitnick,
Jaime Bayona,
Eda Palacios,
Sonya Shin,
Jennifer Furin,
Félix Alcántara,
Epifanio Sánchez,
Madeleny Sarria,
Mercedes C. Becerra,
Mary C. Smith Fawzi,
Saidi Kapiga,
Doneuberg,
James H. Maguire,
Jim Yong Kim,
Paul Farmer
Publication year - 2003
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa022928
Subject(s) - medicine , hazard ratio , tuberculosis , pyrazinamide , ethambutol , surgery , regimen , confidence interval , proportional hazards model , mycobacterium tuberculosis , pathology
Despite the prevalence of multidrug-resistant tuberculosis in nearly all low-income countries surveyed, effective therapy has been deemed too expensive and considered not to be feasible outside referral centers. We evaluated the results of community-based therapy for multidrug-resistant tuberculosis in a poor section of Lima, Peru.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom